🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Study CDFV890G12101 is an open-label, phase 1b, multicenter study with a ra...
Status
Active Not Recruiting
Location
Stanford Cancer Center
Start Date
2023-05-08
Trial ID
NCT05552469
Treatments Being Tested
The purpose of this study is to assess the efficacy of intranasal esketamin...
Status
Completed
Location
Multiple Locations
Start Date
2015-10-01
Trial ID
NCT02493868
The purpose of this study is to find out whether the study drug, LY3537982,...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham
Start Date
2021-07-19
Trial ID
NCT04956640
Treatments Being Tested
To compare continuing bevacizumab + paclitaxel or switching to bevacizumab ...
Status
Completed
Location
Japan Breast Cancer Research Group
Start Date
2014-01
Trial ID
NCT01989780
Treatments Being Tested
This phase 2 study will evaluate the safety, immunogenicity and optimal tim...
Status
Completed
Location
Desmond Tutu HIV Centre Cape Town
Start Date
2005-10
Trial ID
NCT00888446
Treatments Being Tested
Protocol Title A Study to Evaluate ANS014004 in Combination with EGFR-TKI ...
Status
Not Yet Recruiting
Location
Memorial Sloan Kettering Cancer Center David H, Koch Center lor Cancer Care
Start Date
2026-06
Trial ID
NCT07285148
Treatments Being Tested
To assess the efficacy and safety of efficacy of MTS compared to placebo...
Status
Completed
Location
Melmed Center
Start Date
2007-07
Trial ID
NCT00499863
Treatments Being Tested
This screening and multi-sub-study Phase 1b/2 trial will establish a method...
Status
Recruiting
Location
Mayo Clinic Arizona
Start Date
2016-11
Trial ID
NCT03013998
Treatments Being Tested
The purpose of this study is to investigate the efficacy of optimized tempo...
Status
Terminated
Location
Columbia University
Start Date
2006-10
Trial ID
NCT00498940
Treatments Being Tested
Summary Points: 1. High Risk Breast Cancers: Triple negative cancer is con...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-03
Trial ID
NCT05806385
Treatments Being Tested